A technique is described for generation of concentrated respirable aer
osols and their administration to canine lungs. The functional charact
eristics of the system were delineated using aqueous solutions of diso
dium fluorescein (DF). The aerosol was generated by delivering pressur
ized air and disodium fluorescein solution to a Turbotac jet nebulizer
. The particles were dried with a sheath of warm air and concentrated
using a seven orifice virtual impactor. The input aerosol particles we
re concentrated up to eight times, resulting in output aerosol concent
ration of about 10 mg m-3 at a flow rate of 20 1 min-1. The particles
had predictable mass median aerodynamic diameters between 4 and 7 mum,
and geometric standard deviations between 1.7 and 2.0. To conduct inh
alation studies on beagle dogs, the aerosol generation and concentrati
on system was pressurized to 18 cm of water. In these experiments the
test aerosol consisted of a mixture of disodium fluorescein with techn
etium-99m tagged to iron oxide colloid, controlled delivery of the aer
osol to the dogs was achieved by sequencing low resistance solenoid va
lves using a logic control box. The animals were anesthetized and endo
tracheally intubated. The aerosols were carried in the ventilating air
stream. The duration of exposure was 3 min. Gamma scintigraphy confir
med deposition of the aerosol in the lower lungs as demonstrated by a
total lung retention between 70 and 75% after 24 h. This methodology i
s applicable for use with solutions and/or colloidal suspensions and c
an be adapted for continuous aerosol generation and delivery.